Thomas Heineman
Equibles does not estimate personal net worth.
Get an email with a short summary when Oncolytics Biotech Inc publishes a filing, an earnings call transcript or a press release.
Get ONCY alertsAbout Thomas Heineman
The proxy statement of Oncolytics Biotech Inc reports total compensation of $1,197,342 for Thomas Heineman in fiscal 2025, including a base salary of $550,971. Disclosed compensation is on record for 2 fiscal years. Oncolytics Biotech Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oncolytics Biotech Inc includes Jared Kelly (CEO and Board Member), Kirk Look (CFO), John McAdory (COO) and 7 others.
Affiliation history
-
Oncolytics Biotech Inc (ONCY)
Proxy statement
CurrentStart not stated–present
Last confirmed October 6, 2026
Company network
Leadership on record at Oncolytics Biotech Inc
- Jared Kelly CEO, Board Member
- Kirk Look CFO
- John McAdory COO
- Allison Hagerman CTO
- Bernd R. Seizinger Board Member
- Deborah M. Brown Board Member
- James T. Parsons Board Member
- Jonathan Rigby Board Member
- Patricia S. Andrews Board Member
- Stephen Glover Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oncolytics Biotech Inc (ONCY) | Chief Medical Officer | $550,971 | $1,197,342 |
| 2024 | Oncolytics Biotech Inc (ONCY) | Chief Medical Officer | $521,027 | $790,842 |
Recent activity
No call appearances or filed executive changes recorded yet.